Skip to content

Public FDA record

Z-0156-2007: DermaStyle Chroma 2-blue and red light device indicated to be used in treating skin blemishes; portable h

Recall record Z-0156-2007 for Lumiport, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0156-2007
Company in FDA record
Lumiport, LLC
FDA classification date
Nov 7, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Incorrect charger; batteries may overheat , catch fire or explode while being charged with the charger enclosed with the device.

Source facts

Action
Individual customers were contacted through e-mail and/or telephone beginning 09/28/2006. They were told to stop charging and using their current DermaStyle and to destroy it to prevent accidental usage. New replacements will be mailed to all customers.
Initiated
2006-09-28
Root cause
Other
Terminated
2012-03-13
Distribution
World wide Distribution-sales by direct mail or internet-USA and Canada
Recall number
Z-0156-2007
Recall status
Terminated
CDRH record ID
48605
FDA classified
2006-11-07
Recall event number
36406

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗